C260-1326 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(1-{[(3-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)butanamide

C260-1326 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(1-{[(3-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)butanamide
C260-1326 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(1-{[(3-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-1326
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(1-{[(3-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-1326

Molecular Formula

C31H34N4O6 (C31 H34 N4 O6)

Compound Name

N-[2-(3,4-dimethoxyphenyl)ethyl]-4-(1-{[(3-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)butanamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-4-(1-{[(3-methylphenyl)carbamoyl]methyl}-24-dioxo-1234-tetrahydroquinazolin-3-yl)butanamide

SMILES

Cc1cccc(NC(CN(c(cccc2)c2C(N2CCCC(NCCc(cc3)cc(OC)c3OC)=O)=O)C2=O)=O)c1

InChI

InChI=1S/C31H34N4O6/c1-21-8-6-9-23(18-21)33-29(37)20-35-25-11-5-4-10-24(25)30(38)34(31(35)39)17-7-12-28(36)32-16-15-22-13-14-26(40-2)27(19-22)41-3/h4-6,8-11,13-14,18-19H,7,12,15-17,20H2,1-3H3,(H,32,36)(H,33,37)

InChI Key

FNSNLYZTDYVJPW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14737783

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

558.63

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.316

Distribution Coefficient, logD

2.316

Water Solubility, LogSw

-3.10

Polar Surface Area

93.968

Acid Dissociation Constant (pKa)

13.03

Base Dissociation Constant (pKb)

3.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.00

C260-1326 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Antibacterial Compounds Library (13827 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Immune system
  • animal

References: we are preparing a list of scientific research reports with C260-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-1326?
Check Price and Availability of C260-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-1326 available by request